PHARMASEAL, a new provider of clinical trial management and governance solutions, announced that a U.S. health outcomes and technology company has selected Engility Clinical Trial Management system for the management and oversight of its clinical trial programs.
In the field of health outcomes and technology, companies are looking to leverage big clinical data and artificial intelligence (AI) to better understand, compare, and predict patient outcomes. The task of combining real-world evidence (RWE), clinical registries and AI technologies can be challenging. Engility was chosen to provide a validated system for managing clinical trial information, reduce data duplication and improve trial collaboration.
Engility CTMS is a modern cloud-based enterprise trial management system used by medical device, biopharmaceutical, and CRO’s to aim to improve how they manage and control clinical trials. With support for multiple sourcing models, flexible trial designs including centralized/virtual/remote trials, Engility CTMS is ideally placed to support good clinical practice (GCP E6) requirements and spearhead clinical operational process improvements.
Daljit Cheema, Founder and CEO of PHARMASEAL commented, “We are delighted that our integrated enterprise platform, Engility, has been selected and licensed to help drive new insights for this company. Our innovative platform utilizes advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimize governance and oversight. At PHARMASEAL, we have the vision to create smarter technologies for the improvement of human health and we are excited to see what possibilities emerge from this collaboration for transforming the future of healthcare.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.